跳至主要内容
临床试验/DRKS00009855
DRKS00009855已完成不适用

Spinal cord injury-induced immude deficiency Syndrome: Natuarl killer (NK) cell functionality after spinal cord injury - SCI-IDS: NK cells function

Charité Campus Charité Mitte0 个研究点目标入组 67 人开始时间: 2016年1月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
67

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with acute isolated spinal cord injury (AIS A-D) planned
  • for surgical stabilization and decompression, lesion may include
  • more than 1 segment
  • - Patients with acute isolated spinal fracture planned for surgical
  • stabilization, lesion may include more than 1 segment
  • - = 2 spinal cord or vertebral lesions definable one from another
  • - Documented informed consent of the patient

排除标准

  • - Non-traumatic spinal cord injury
  • - 2 or more spinal cord or vertebral lesions definable one from
  • - Severe polytrauma (definition: patients with severe injuries of
  • life-sustaining organ systems, which per se and in the acute phase
  • are life-threatening (e.g., severe pelvic trauma, severe body cavity
  • - Concomitant traumatic brain injury (TBI) (definition: i) Patients
  • with persisting neurological deficit in consequence of the TBI, ii)
  • patient with severe TBI (Glasgow Coma Scale = 8), and iii) patients
  • with intracranial pressure monitoring sensors.)
  • - Neoplasia and/or antineoplastic therapy
  • - Rheumatic disease, collagenosis, vasculitis or other autoimmune
  • - Preexisting chronic infectious disease (before the injury)
  • - Preexisting systemic steroid treatment
  • - Severe alcohol or drug addiction
  • - Pregnancy, lactation

研究者

发起方
Charité Campus Charité Mitte

相似试验